Your browser doesn't support javascript.
loading
Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas.
Caughey, Bennett A; Umemoto, Kumiko; Green, Michelle F; Ikeda, Masafumi; Lowe, Melissa E; Ueno, Makoto; Niedzwiecki, Donna; Taniguchi, Hiroya; Walden, Daniel J; Komatsu, Yoshito; D'Anna, Rachel; Esaki, Taito; Denda, Tadamichi; Datto, Michael B; Bando, Hideaki; Bekaii-Saab, Tanios; Yoshino, Takayuki; Strickler, John H; Nakamura, Yoshiaki.
Affiliation
  • Caughey BA; Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
  • Umemoto K; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Green MF; Department of Pathology, Duke University Medical Center, Durham, NC, USA.
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Lowe ME; Duke Cancer Institute-Biostatistics Shared Resource, Durham, NC, USA.
  • Ueno M; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Niedzwiecki D; Duke Cancer Institute-Biostatistics Shared Resource, Durham, NC, USA.
  • Taniguchi H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Walden DJ; Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Komatsu Y; Department of Cancer Center, Hokkaido University Hospital, Sapporo, Japan.
  • D'Anna R; Duke Cancer Institute-Biostatistics Shared Resource and Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
  • Esaki T; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Denda T; Division of Gastroenterology, Chiba Cancer Center, Chiba, Japan.
  • Datto MB; Department of Pathology, Duke University Medical Center, Durham, NC, USA.
  • Bando H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Bekaii-Saab T; Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Strickler JH; Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
  • Nakamura Y; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
J Gastrointest Oncol ; 14(5): 2083-2096, 2023 Oct 31.
Article de En | MEDLINE | ID: mdl-37969845
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: J Gastrointest Oncol Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: J Gastrointest Oncol Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique